Target intelligence / Profile preview

Bacterial type II topoisomerase (Topo II (Bacterial))

Target
Topo II (Bacterial)
Molecular classification
Enzyme, Topoisomerase, Type II topoisomerase, Type IIA topoisomerase
01

Overview

Bacterial type II topoisomerase refers to a group of essential enzymes, primarily DNA gyrase and topoisomerase IV, that regulate the topological state of the bacterial genome during DNA replication, transcription, and recombination [1, 5, 11]. DNA gyrase is unique in its ability to introduce negative supercoils into DNA, a process vital for chromosome compaction and the relief of torsional stress [5, 15]. Topoisomerase IV is primarily responsible for the decatenation of interlinked daughter chromosomes, allowing for successful cell division [5, 13]. These enzymes are heterotetrameric complexes consisting of two distinct subunits (GyrA/GyrB or ParC/ParE) and are the primary targets of fluoroquinolone antibiotics [4, 11, 13]. Fluoroquinolones function as topoisomerase poisons by trapping the enzyme in a covalent complex with DNA, leading to the accumulation of lethal double-strand breaks [2, 6, 15]. Other inhibitors, such as aminocoumarins, target the ATPase domain to block the energy-dependent catalytic cycle [1, 11]. Given the rise of antibiotic resistance, these enzymes remain critical targets for the development of novel antibacterial agents with distinct mechanisms of action [3, 13].

Other names
DNA gyraseTopoisomerase IVBacterial type IIA topoisomeraseBacterial DNA topoisomerase II
02

Mechanism of action

Inhibition of DNA ligation and stabilization of the enzyme-DNA cleavage complex (topoisomerase poisons); competitive inhibition of ATPase activity; inhibition of DNA supercoiling and decatenation.

03

Biological functions

DNA replicationDNA transcriptionDNA supercoilingDecatenationDNA relaxationChromosome condensation
04

Disease associations

Infection
05

Safety considerations

Tendonitis and tendon ruptureCentral nervous system effects (seizures, anxiety)QT interval prolongationPeripheral neuropathyAortic aneurysm and dissectionDevelopment of multidrug resistance
06

Interacting drugs

Ciprofloxacin

8 more in the full profile.

07

Biomarkers

gyrA mutationsgyrB mutationsparC mutationsparE mutationsQuinolone Resistance-Determining Region (QRDR) mutations

Beyond the preview

Go deeper on Bacterial type II topoisomerase (Topo II (Bacterial)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial type II topoisomerase (Topo II (Bacterial)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call